BackChromocell Therapeutics Overview

Chromocell Therapeutics Other Current Assets

Chromocell Therapeutics's other current assets is $2.7M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$2.71M
247.11% YoYΔ $1.93M vs prior year quarter

Peer average

Loading

Chromocell Therapeutics Other Current Assets History

Loading

Chromocell Therapeutics vs. peers: Other Current Assets Comparison

Loading

Chromocell Therapeutics Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chromocell Therapeutics (CHRO) FAQ

As of the most recent data (March 2026), CHRO shows a other current assets of $2.7M. That compares with $780K in the prior-year period — up 247.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CHRO's other current assets is now $2.7M (was $780K) — a 247.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Chromocell Therapeutics is outperforming or lagging.

Tracking CHRO's other current assets over time shows whether Chromocell Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $2.7M That compares with $780K in the prior-year period — up 247.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Chromocell Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $2.7M) with ownership activity and broader fundamentals.